Massimo Gion

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Disorders

Anatomy

Cytosol

Procedures

Concepts & Ideas

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Secreto Giorgio; Venturelli Elisabetta; Meneghini Elisabetta; Greco Marco; Ferraris Cristina; Gion Massimo; Zancan Matelda; Fabricio Aline S C; Berrino Franco; Cavalleri Adalberto; Micheli Andrea
Testosterone and biological characteristics of breast cancers in postmenopausal women.
Zancan Matelda; Galdi Francesca; Di Tonno Fulvio; Mazzariol Chiara; Orlando Claudio; Malentacchi Francesca; Agostini Marco; Maran Michela; Del Bianco Paola; Fabricio Aline S C; Murer Bruno; Pianon Carlo; Gion Massimo
Evaluation of cell-free DNA in urine as a marker for bladder cancer diagnosis.
Mariani Luigi; Miceli Rosalba; Michilin Silvia; Gion Massimo
Serial determination of CEA and CA 15.3 in breast cancer follow-up: an assessment of their diagnostic accuracy for the detection of tumour recurrences.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Massimo Gion (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Secreto Giorgio; Venturelli Elisabetta; Meneghini Elisabetta; Greco Marco; Ferraris Cristina; Gion Massimo; Zancan Matelda; Fabricio Aline S C; Berrino Franco; Cavalleri Adalberto; Micheli Andrea
Testosterone and biological characteristics of breast cancers in postmenopausal women.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(11):2942-8.
2009: Zancan Matelda; Galdi Francesca; Di Tonno Fulvio; Mazzariol Chiara; Orlando Claudio; Malentacchi Francesca; Agostini Marco; Maran Michela; Del Bianco Paola; Fabricio Aline S C; Murer Bruno; Pianon Carlo; Gion Massimo
Evaluation of cell-free DNA in urine as a marker for bladder cancer diagnosis.
The International journal of biological markers 2009;24(3):147-55.
2009: Mariani Luigi; Miceli Rosalba; Michilin Silvia; Gion Massimo
Serial determination of CEA and CA 15.3 in breast cancer follow-up: an assessment of their diagnostic accuracy for the detection of tumour recurrences.
Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 2009;14(2):130-6.
2008: Roveri Antonella; Vitale Maria Pia; Serain Elena; Zaccarin Mattia; Mauri Pierluigi; Di Silvestre Dario; De Palma Antonella; Gion Massimo; Toppo Stefano; Maiorino Matilde; Ursini Fulvio
Differential liquid phase proteomic analysis of the effect of selenium supplementation in LNCaP cells.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2008;865(1-2):63-73.
2008: Dittadi Ruggero; Peloso Lucia; Gion Massimo
Within-subject biological variation in disease: the case of tumour markers.
Annals of clinical biochemistry 2008;45(Pt 2):226-7; author reply 227.
2008: Dittadi Ruggero; Gelisio Paola; Rossi Loredana; Frigato Francesco; Gion Massimo
Biological variability evaluation and comparison of three different methods for C-peptide measurement.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2008;46(10):1480-2.
2008: Molina Rafael; Gion Massimo; Gressner Axel; Troalen Frédéric; Auge Jose Maria; Holdenrieder Stefan; Zancan Matelda; Wycislo Matthias; Stieber Petra
Alternative antibody for the detection of CA15-3 antigen: a European multicenter study for the evaluation of the analytical and clinical performance of the Access BR Monitor assay on the UniCel Dxl 800 Immunoassay System.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2008;46(5):612-22.
2008: Stieber Petra; Molina Rafael; Gion Massimo; Gressner Axel; Troalen Frédéric; Holdenrieder Stefan; Auge Jose Maria; Zancan Matelda; Wycislo Matthias; Jarrige Véronique
Alternative antibody for the detection of CA19-9 antigen: a European multicenter study for the evaluation of the analytical and clinical performance of the Access GI Monitor assay on the UniCel Dxl 800 Immunoassay System.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2008;46(5):600-11.
2008: Holdenrieder Stefan; Molina Rafael; Gion Massimo; Gressner Axel; Troalen Frédéric; Auge Jose Maria; Zancan Matelda; Wycislo Matthias; Stieber Petra
Alternative antibody for the detection of CA125 antigen: a European multicenter study for the evaluation of the analytical and clinical performance of the Access OV Monitor assay on the UniCel Dxl 800 Immunoassay System.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2008;46(5):588-99.
2007: Zatelli Maria Chiara; Torta Mirella; Leon Antonette; Ambrosio Maria Rosaria; Gion Massimo; Tomassetti Paola; De Braud Filippo; Delle Fave Gianfranco; Dogliotti Luigi; degli Uberti Ettore C;
Chromogranin A as a marker of neuroendocrine neoplasia: an Italian Multicenter Study.
Endocrine-related cancer 2007;14(2):473-82.
2007: Dittadi R; Franceschini R; Fortunato A; Zancan M; Barichello M; Tasca A; Giavarina D; Peloso L; Soffiati G; Gion M
Interchangeability and diagnostic accuracy of two assays for total and free prostate-specific antigen: two not always related items.
The International journal of biological markers 2007;22(2):154-8.
2007: Gasparini Giampietro; Gion Massimo; Mariani Luigi; Papaldo Paola; Crivellari Diana; Filippelli Gianfranco; Morabito Alessandro; Silingardi Vittorio; Torino Francesco; Spada Antonella; Zancan Matelda; De Sio Livia; Caputo Antonio; Cognetti Francesco; Lambiase Antonio; Amadori Dino
Randomized Phase II Trial of weekly paclitaxel alone versus trastuzumab plus weekly paclitaxel as first-line therapy of patients with Her-2 positive advanced breast cancer.
Breast cancer research and treatment 2007;101(3):355-65.
2007: Bertaccini Alessandro; Fandella Andrea; Prayer-Galetti Tommaso; Scattoni Vincenzo; Galosi Andrea B; Ficarra Vincenzo; Trombetta Carlo; Gion Massimo; Martorana Giuseppe;
Systematic development of clinical practice guidelines for prostate biopsies: a 3-year Italian project.
Anticancer research 2007;27(1B):659-66.
2007: Verderio Paolo; Dittadi Ruggero; Marubini Ettore; Pizzamiglio Sara; Gion Massimo; De Apollonia Leandro; Paradiso Angelo;
An Italian program of External Quality Control for chromogranin A (CgA) assay: performance evaluation of CgA determination.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2007;45(9):1244-50.
2006: Trevisiol C; Di Fabio F; Nascimbeni R; Peloso L; Salbe C; Ferruzzi E; Salerni B; Gion M
Prognostic value of circulating KRAS2 gene mutations in colorectal cancer with distant metastases.
The International journal of biological markers 2006;21(4):223-8.
2005: Gasparini G; Sarmiento R; Amici S; Longo R; Gattuso D; Zancan M; Gion M
Gefitinib (ZD1839) combined with weekly epirubicin in patients with metastatic breast cancer: a phase I study with biological correlate.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(12):1867-73.
2005: Leon A; Torta M; Dittadi R; degli Uberti E; Ambrosio M R; Delle Fave G; De Braud F; Tomassetti P; Gion M; Dogliotti L
Comparison between two methods in the determination of circulating chromogranin A in neuroendocrine tumors (NETs): results of a prospective multicenter observational study.
The International journal of biological markers 2005;20(3):156-68.
2005: Gasparini Giampietro; Meo Sabrina; Comella Giuseppe; Stani Simonetta Chiara; Mariani Luigi; Gamucci Teresa; Avallone Antonio; Lo Vullo Salvatore; Mansueto Giovanni; Bonginelli Paola; Gattuso Domenico; Gion Massimo
The combination of the selective cyclooxygenase-2 inhibitor celecoxib with weekly paclitaxel is a safe and active second-line therapy for non-small cell lung cancer: a phase II study with biological correlates.
Cancer journal (Sudbury, Mass.) 2005;11(3):209-16.
2005: Zancan M; Franceschini R; Mimmo C; Vianello M; Di Tonno F; Mazzariol C; Malossini G; Gion M
Free DNA in urine: a new marker for bladder cancer? Preliminary data.
The International journal of biological markers 2005;20(2):134-6.
2005: Meo Sabrina; Dittadi Ruggero; Gion Massimo;
Biological variation of vascular endothelial growth factor.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2005;43(3):342-3.
2004: Pezzato Elga; Sartor Luigi; Dell'Aica Isabella; Dittadi Ruggero; Gion Massimo; Belluco Claudio; Lise Mario; Garbisa Spiridione
Prostate carcinoma and green tea: PSA-triggered basement membrane degradation and MMP-2 activation are inhibited by (-)epigallocatechin-3-gallate.
International journal of cancer. Journal international du cancer 2004;112(5):787-92.
2004: Meo S; Dittadi R; Peloso L; Gion M
The prognostic value of vascular endothelial growth factor, urokinase plasminogen activator and plasminogen activator inhibitor-1 in node-negative breast cancer.
The International journal of biological markers 2004;19(4):282-8.
2004: Dittadi Ruggero; Meo Sabrina; Gion Massimo;
Biological variation of plasma chromogranin A.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2004;42(1):109-10.
2003: Dittadi R; Gion M
Interchangeability between control material and patient serum in tumor biomarker assessment.
The International journal of biological markers 2003;18(3):230-1.
2003: Ferruzzi E; Franceschini R; Cazzolato G; Geroni C; Fowst C; Pastorino U; Tradati N; Tursi J; Dittadi R; Gion M
Blood glutathione as a surrogate marker of cancer tissue glutathione S-transferase activity in non-small cell lung cancer and squamous cell carcinoma of the head and neck.
European journal of cancer (Oxford, England : 1990) 2003;39(7):1019-29.
2003: Morabito Alessandro; Magnani Elena; Gion Massimo; Sarmiento Roberta; Capaccetti Barbara; Longo Raffaele; Gattuso Domenico; Gasparini Giampietro
Prognostic and predictive indicators in operable breast cancer.
Clinical breast cancer 2003;3(6):381-90.
2003: Gion M
Prognostic and predictive molecular markers: are we ready for their clinical use? The opinion of a clinical biochemist.
The International journal of biological markers 2003;18(1):62-4.
2002: Trombetta Carlo; Guazzieri Stefano; Martorana Giuseppe; Gion Massimo; Fandella Andrea; Bertaccini Alessandro; Liguori Giovanni
[Response to a cognitive questionnaire on the guideline project of prostatic biopsy of the SIEUN--GUONE--SIUrO--SIBioC]
Archivio italiano di urologia, andrologia : organo ufficiale [di] Società italiana di ecografia urologica e nefrologica / Associazione ricerche in urologia 2002;74(4):190-6.
2002: Vermeulen P B; Gasparini G; Fox S B; Colpaert C; Marson L P; Gion M; Beliën J A M; de Waal R M W; Van Marck E; Magnani E; Weidner N; Harris A L; Dirix L Y
Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours.
European journal of cancer (Oxford, England : 1990) 2002;38(12):1564-79.
2002: Paradiso A; Volpe S; Iacobacci A; Marubini E; Verderio P; Costa A; Daidone M G; Marchetti A; Mottolese M; Amadori D; De Paola F; Saragoni L; Medri L; Nenci I; Querzoli P; Gion M; Dittadi R; Plebani M; Orlando C; Bevilacqua G; Silvestrini R;
Quality control for biomarker determination in oncology: the experience of the Italian Network for Quality Assessment of Tumor Biomarkers (INQAT).
The International journal of biological markers 2002;17(3):201-14.
2002: Gion M; Boracchi P; Dittadi R; Biganzoli E; Peloso L; Mione R; Gatti C; Paccagnella A; Marubini E
Prognostic role of serum CA15.3 in 362 node-negative breast cancers. An old player for a new game.
European journal of cancer (Oxford, England : 1990) 2002;38(9):1181-8.
2001: Dittadi R; Zancan M; Perasole A; Gion M
Evaluation of HER-2/neu in serum and tissue of primary and metastatic breast cancer patients using an automated enzyme immunoassay.
The International journal of biological markers 2001;16(4):255-61.
2001: Gion M; Peloso L; Mione R; Vignati G; Fortunato A; Saracchini S; Biasioli R; Gulisano M; Cappelli G
Tumor markers in breast cancer monitoring should be scheduled according to initial stage and follow-up time: a prospective study on 859 patients.
Cancer journal (Sudbury, Mass.) 2001;7(3):181-90.
2001: Dittadi R; Meo S; Fabris F; Gasparini G; Contri D; Medici M; Gion M
Validation of blood collection procedures for the determination of circulating vascular endothelial growth factor (VEGF) in different blood compartments.
The International journal of biological markers 2001;16(2):87-96.
2001: Gion M; Mione R; Leon A E; Lüftner D; Molina R; Possinger K; Robertson J F
CA27.29: a valuable marker for breast cancer management. A confirmatory multicentric study on 603 cases.
European journal of cancer (Oxford, England : 1990) 2001;37(3):355-63.
2001: Gasparini G; Toi M; Biganzoli E; Dittadi R; Fanelli M; Morabito A; Boracchi P; Gion M
Thrombospondin-1 and -2 in node-negative breast cancer: correlation with angiogenic factors, p53, cathepsin D, hormone receptors and prognosis.
Oncology 2001;60(1):72-80.
2000: Gasparini G; Gion M
Molecular-targeted anticancer therapy: challenges related to study design and choice of proper endpoints.
Cancer journal (Sudbury, Mass.) 2000;6(3):117-31.
2000: Gion M; Mione R; Barioli P; Barichello M; Zattoni F; Prayer-Galetti T; Plebani M; Aimo G; Terrone C; Manferrari F; Madeddu G; Caberlotto L; Fandella A; Pianon C; Vianello L; Amoroso B
Clinical evaluation of percent free prostate-specific antigen using the AxSYM system in the best analytical scenario.
European urology 2000;37(4):460-9.
2000: Gion M; Boracchi P; Dittadi R; Biganzoli E; Peloso L; Gatti C; Paccagnella A; Rosabian A; Vinante O; Meo S
Quantitative measurement of soluble cytokeratin fragments in tissue cytosol of 599 node negative breast cancer patients: a prognostic marker possibly associated with apoptosis.
Breast cancer research and treatment 2000;59(3):211-21.
1999: Toi M; Gion M; Saji H; Asano M; Dittadi R; Gilberti S; Locopo N; Gasparini G
Endogenous interleukin-12: relationship with angiogenic factors, hormone receptors and nodal status in human breast carcinoma.
International journal of oncology 1999;15(6):1169-75.
1999: Gion M; Boracchi P; Biganzoli E; Daidone M G
A guide for reviewing submitted manuscripts (and indications for the design of translational research studies on biomarkers)
The International journal of biological markers 1999;14(3):123-33.
1999: Gion M; Mione R; Leon A E; Dittadi R
Comparison of the diagnostic accuracy of CA27.29 and CA15.3 in primary breast cancer.
Clinical chemistry 1999;45(5):630-7.
1999: Gasparini G; Toi M; Miceli R; Vermeulen P B; Dittadi R; Biganzoli E; Morabito A; Fanelli M; Gatti C; Suzuki H; Tominaga T; Dirix L Y; Gion M
Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy.
The cancer journal from Scientific American 1999;5(2):101-11.
1998: Gion M; Mione R; Barioli P; Barichello M; Zattoni F; Prayer-Galetti T; Plebani M; Aimo G; Terrone C; Manferrari F; Madeddu G; Caberlotto L; Fandella A; Pianon C; Vianello L
Percent free prostate-specific antigen in assessing the probability of prostate cancer under optimal analytical conditions.
Clinical chemistry 1998;44(12):2462-70.
1998: Dittadi R; Coradini D; Meo S; Pirronello E; Daidone M G; Gion M
Tissue polypeptide antigen as a putative indicator of apoptosis.
Clinical chemistry 1998;44(9):2002-3.
1998: Gion M; Barioli P; Ponti A; Torri V; Mione R; Dittadi R
How tumor markers are used in the routine follow-up of breast and colorectal cancer. A survey of 29 Italian hospitals.
The International journal of biological markers 1998;13(3):124-38.
1998: Biganzoli E; Boracchi P; Daidone M G; Gion M; Marubini E
Flexible modelling in survival analysis. Structuring biological complexity from the information provided by tumor markers.
The International journal of biological markers 1998;13(3):107-23.
1998: Mione R; Barioli P; Barichello M; Zattoni F; Prayer-Galetti T; Plebani M; Aimo G; Terrone C; Manferrari F; Madeddu G; Caberlotto L; Fandella A; Pianon C; Vianello L; Gion M
Prostate cancer probability after total PSA and percent free PSA determination.
The International journal of biological markers 1998;13(2):77-86.
1998: Dittadi R; Biganzoli E; Boracchi P; Salbe C; Mione R; Gatti C; Gion M
Impact of steroid receptors, pS2 and cathepsin D on the outcome of N+ postmenopausal breast cancer patients treated with tamoxifen.
The International journal of biological markers 1998;13(1):30-41.
1998: Gion M; Barioli P; Ponti A; Torri V; Mione R; Dittadi R
How CA 125 is used in the routine follow-up of ovarian cancer: a survey of 29 Italian hospitals.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1998;19(4):269-74.
1997: Dittadi R; Brazzale A; Mione R; Di Fresco S; Gatti C; Vinante O; Bassan F; Nascimben O; Gion M
Quantitative chemiluminescent immunoassay of p53: prognostic significance in 220 node-negative breast cancer tissue.
Anticancer research 1997;17(6D):4691-6.
1997: Dittadi R; Brazzale A; Pappagallo G; Salbe C; Nascimben O; Rosabian A; Gion M
ErbB2 assay in breast cancer: possibly improved clinical information using a quantitative method.
Anticancer research 1997;17(2B):1245-7.
1997: Dittadi R; Meo S; Amoroso B; Gion M
Detection of different estrogen receptor forms in breast cancer cytosol by enzyme immunoassay.
Cancer research 1997;57(6):1066-72.
1996: Mione R; Aimo G; Bombardieri E; Cianetti A; Correale M; Barioli P; Barichello M; Terrone C; Massaron S; Seregni E; Marzano D; Abbate I; Pagliarulo A; Gion M
Preliminary results of clinical evaluation of the free/total prostate-specific antigen ratio in a multicentric study.
Tumori 1996;82(6):543-9.
1996: Dittadi R; Barioli P; Gion M; Mione R; Barichello M; Capitanio G; Cocco G; Cazzolato G; De Biasi F; Praturlon S; Antinozzi R; Gianneo E
Standardization of assay for cytokeratin-related tumor marker CYFRA21.1 in urine samples.
Clinical chemistry 1996;42(10):1634-8.
1996: Pelizzola D; Gion M; Paradiso A; Dittadi R; Correale M; Mione R; Piffanelli A
Cathepsin D versus other prognostic factors in breast cancer. Results and controversies of a multicenter study on 2575 cases.
The International journal of biological markers 1996;11(3):139-47.
1996: Dittadi R; Calderazzo F; Cabrelle A; Di Fresco S; Gion M; Chieco-Bianchi L
c-erbB-2/neu protein expression, DNA ploidy and S phase in breast cancer.
Cell proliferation 1996;29(7):403-12.
1996: Gion M; Mione R; Barioli P; Dittadi R
Dynamic use of tumor markers, rationale-clinical applications and pitfalls.
Anticancer research 1996;16(4B):2279-84.
1996: Piffanelli A; Dittadi R; Catozzi L; Gion M; Capitanio G; Gelli M C; Brazzale A; Malagutti R; Pelizzola D; Menegon A; Giovannini G; Gardini G
Determination of ErbB2 protein in breast cancer tissues by different methods. Relationships with other biological parameters.
Breast cancer research and treatment 1996;37(3):267-76.
1995: Mione R; Barichello M; Sartorello P; Leon A; Barioli P; Gion M
Third-generation PSA: ultrasensitive or ultraprecise assay?
The International journal of biological markers 1995;10(4):229-33.
1995: Pilo A; Zucchelli G C; Cohen R; Bizollon C A; Cappelli G; Cianetti A; Gion M; Piffanelli A; Bombardieri E
Comparison of immunoassays for tumor markers CA 19-9, CA 15-3 and CA 125: data from an international quality assessment scheme.
Tumori 1995;81(2):117-24.
1995: Gion M; Barioli P; Mione R; Cappelli G; Vignati G; Fortunato A; Saracchini S; Biasioli R; Gulisano M
Tumor markers in breast cancer follow-up: a potentially useful parameter still awaiting definitive assessment. Forza Operativa Nazionale sul Carcinoma Mammario (FONCaM).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1995;6 Suppl 2():31-5.
1995: Gion M; Mione R; Dittadi R; Romanelli M; Pappagallo L; Capitanio G; Friede U; Barbazza R; Visonà A; Dante S
Relationship between cathepsin D and other pathological and biological parameters in 1752 patients with primary breast cancer.
European journal of cancer (Oxford, England : 1990) 1995;31A(5):671-7.
1995: Barichello M; Gion M; Bonazza A; Delli Ponti U S; Bolgan A; Contemori G P; Barioli P; Capitanio G; Pecori B; Omacini S
Prostate-specific antigen as a unique routine test in monitoring therapy for inoperable prostate cancer: comparison with radionuclide bone scan and prostatic acid phosphatase.
European urology 1995;27(4):295-300.
1994: Gion M; Mione R; Barioli P; Sartorello P; Capitanio G
Tissue polypeptide antigen and tissue polypeptide specific antigen in primary breast cancer. Evaluation in serum and tumour tissue.
European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies 1994;32(10):779-87.
1994: Correale M; Arnberg H; Blockx P; Bombardieri E; Castelli M; Encabo G; Gion M; Klapdor R; Martin M; Nilsson S
Clinical profile of a new monoclonal antibody-based immunoassay for tissue polypeptide antigen.
The International journal of biological markers 1994;9(4):231-8.
1994: Gion M; Dittadi R; Mione R; Pagan V; Busetto A
Preliminary evaluation of CYFRA 21-1 in lung cancer cytosol.
The International journal of biological markers 1994;9(4):258-9.
1994: Gion M; Cappelli G; Mione R; Pistorello M; Meo S; Vignati G; Fortunato A; Saracchini S; Biasioli R; Giulisano M
Evaluation of critical differences of CEA and CA 15.3 levels in serial samples from patients operated for breast cancer.
The International journal of biological markers 1994;9(3):135-9.
1994: Gion M; Plebani M; Mione R; Penzo C; Meo S; Burlina A
Serum CA549 in primary breast cancer: comparison with CA15.3 and MCA.
British journal of cancer 1994;69(4):721-5.
1994: Gion M; Mione R; Becciolini A; Balzi M; Correale M; Piffanelli A; Giovannini G; Saccani Jotti G; Fontanesi M
Relationship between cytosol TPS, TPA and cell proliferation.
The International journal of biological markers 1994;9(2):109-14.
1994: Gion M; Mione R; Barioli P; Sartorello P; Dal Zennaro E; Gasparini C; Marconato R
The correlation between serum levels of cytokeratin tumor markers does reflect their molecular characterization.
The International journal of biological markers 1994;9(2):121-2.
1994: Gion M; Mione R; Pappagallo G L; Gatti C; Nascimben O; Sampognaro E; Meo S
Biochemical parameters for prognostic evaluation in patients with breast cancer.
Anticancer research 1994;14(2B):693-8.
1993: Dittadi R; Catozzi L; Gion M; Brazzale A; Capitanio G; Gelli M C; Menegon A; Gardini G; Malagutti R; Piffanelli A
Comparison between western blotting, immunohistochemical and ELISA assay for p185neu quantitation in breast cancer specimens.
Anticancer research 1993;13(5C):1821-4.
1993: Gion M; Mione R; Pappagallo G L; Gatti C; Nascimben O; Bari M; Leon A E; Vinante O; Bruscagnin G
PS2 in breast cancer--alternative or complementary tool to steroid receptor status? Evaluation of 446 cases.
British journal of cancer 1993;68(2):374-9.
1993: Gion M; Ruggeri G; Mione R; Marconato R; Casella C; Nosadini A; Simoncini E; Belloli S; Dal Zennaro E; Bruscagnin G
A new approach to tumour marker assessment by perioperative determination in breast and colorectal cancer.
The International journal of biological markers 1993;8(1):8-13.
1993: Dittadi R; Donisi P M; Brazzale A; Cappellozza L; Bruscagnin G; Gion M
Epidermal growth factor receptor in breast cancer. Comparison with non malignant breast tissue.
British journal of cancer 1993;67(1):7-9.
1993: Gion M; Cappelli G; Mione R; Vignati G; Fortunato A; Saracchini S; Biasioli R; Gulisano M
Variability of tumor markers in the follow-up of patients radically resected for breast cancer.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1993;14(6):325-33.
1992: Dittadi R; Donisi P M; Brazzale A; Marconato R; Spina M; Gion M
Immunoenzymatic assay of erbB2 protein in cancer and non-malignant breast tissue. Relationships with clinical and biochemical parameters.
Anticancer research 1992;12(6B):2005-10.
1992: Saccani Jotti G; Grassi C; Fontanesi M; Becchi G; Gion M
CEA, TPA and CA 15.3 in tissue and serum of breast cancer patients.
The International journal of biological markers 1992;7(4):265-6.
1992: Gion M; Rampazzo A; Mione R; Bruscagnin G
Cost/effectiveness ratio of carcinoembryonic antigen--importance of adequacy of routine requests of tumor markers.
The International journal of biological markers 1992;7(3):179-82.
1992: Gion M; Mione R; Pappagallo G L; Gatti C; Nascimben O; Brandes A; Vinante O; Bruscagnin G
Tissue polypeptide antigen in breast cancer cytosol: a new effective prognostic indicator.
European journal of cancer (Oxford, England : 1990) 1992;29A(1):66-9.
1992: Omacini S; Mione R; Barichello M; Santucci Delli Ponti U; Bolgan A; Contemori G P; Petracco S; Capitanio G; Donisi P M; Gion M
Relationship between prostatic acid phosphatase and prostate-specific antigen serum levels and prostatic volume in benign prostate hyperplasia. Pitfall on tumor markers assessment in primary prostatic cancer?
European urology 1992;21 Suppl 1():108-10.
1991: Dittadi R; Gion M; Pagan V; Brazzale A; Del Maschio O; Bargossi A; Busetto A; Bruscagnin G
Epidermal growth factor receptor in lung malignancies. Comparison between cancer and normal tissue.
British journal of cancer 1991;64(4):741-4.
1991: Di Lorenzo D; Ruggeri G; Iacobello C; Belloli S; Gion M; Zava D T; Ghielmi S; Albertini A
Evaluation of a radioreceptor assay to assess exogenous estrogen activity in serum of patients with breast cancer.
The International journal of biological markers 1991;6(3):151-8.
1991: Taccone W; Gion M; Pecchio F; Rapellino M; Tremolada C; Mione R; Gatti C; Ruol A; Segalin A; Dei Poli M
TAF test in primary esophageal carcinoma: comparison with other tumor markers.
The International journal of biological markers 1991;6(3):173-6.
1991: Gion M; Mione R; Nascimben O; Valsecchi M; Gatti C; Leon A; Bruscagnin G
The tumour associated antigen CA15.3 in primary breast cancer. Evaluation of 667 cases.
British journal of cancer 1991;63(5):809-13.
1991: Gion M; Dittadi R; Leon A E; Bruscagnin G; Pelizzola D; Giovannini G; Giganti M; Messeri G; Quercioli M; Flamini E
Comparison between single saturating dose ligand binding assay and enzyme immunoassay for low-salt extractable oestrogen and progesterone receptors in breast cancer: a multicentre study.
European journal of cancer (Oxford, England : 1990) 1991;27(8):996-1002.
1991: Gion M; Mione R; Tremolada C; Dalla Palma P; Ruol A; Dittadi R; Leon A; Nosadini A; Castoro C; Bruscagnin G
Tumor-associated trypsin inhibitor (TATI) in primary esophageal carcinoma.
Scandinavian journal of clinical and laboratory investigation. Supplementum 1991;207():37-41.
1990: Gion M; Mione R; Gatti C; Dittadi R; Leon A; Castiglioni C; Nascimben O; Bruscagnin G
Tissue polypeptide antigen in tumor cytosol: a new prognostic indicator in primary breast cancer.
Breast cancer research and treatment 1990;17(1):15-21.
1990: Gion M; Ruggeri G; Marconato R; Casella C; Nosadini A; Laffranchini G; Mione R; Belloli S; Bruscagnin G
Perioperatory kinetic evaluation of tumor markers in breast and colorectal carcinoma.
The Journal of nuclear medicine and allied sciences 1990;34(4 Suppl):9-12.
1990: Dittadi R; Gion M; Brazzale A; Bruscagnin G
Immunoprecipitation method for a radioligand binding assay of epidermal growth factor receptor.
The Journal of nuclear medicine and allied sciences 1990;34(4 Suppl):225-30.
1990: Gion M; Fila G; Biasioli R; Vignati G; Mione R; Saracchini S; Rinaldi E; Testa E; Bruscagnin G
Kinetic use of tumor markers in the follow-up of patients operated for primary breast cancer.
The Journal of nuclear medicine and allied sciences 1990;34(4 Suppl):1-7.
1990: Gion M; Mione R; Gatti C; Dittadi R; Leon A; Nascimben O; Pizzorno B; Bruscagnin G
Is tissue polypeptide antigen still a useful tumor marker in breast carcinoma? Comparison with CA15.3 and MCA.
Tumori 1990;76(4):360-4.
1990: Mione R; Bombardieri E; Gion M; Gatti C; Bruscagnin G
Evaluation of a new IRMA method for the determination of neuron specific enolase.
The International journal of biological markers 1990;5(3):155-6.
1990: Dittadi R; Gion M; Brazzale A; Bruscagnin G
Radioligand binding assay of epidermal growth factor receptor: causes of variability and standardization of the assay.
Clinical chemistry 1990;36(6):849-54.
1990: Gion M; Tremolada C; Mione R; Dittadi R; Della Palma P; Castoro C; Ruol A; Nosadini A; Peracchia A; Bruscagnin G
Tumor markers in squamous cell carcinoma of esophagus: immunometric assay in cytosol and membrane fraction.
The International journal of biological markers 1990;5(1):7-13.
1989: Gion M; Tremolada C; Mione R; della Palma P; Dittadi R; Zari C; Nosadini A; Castoro C; Ruol A; Peracchia A
Tumor markers in serum of patients with primary squamous cell carcinoma of the esophagus.
Tumori 1989;75(5):489-93.
1989: Bombardieri E; Gion M; Mione R; Dittadi R; Bruscagnin G; Buraggi G
A mucinous-like carcinoma-associated antigen (MCA) in the tissue and blood of patients with primary breast cancer.
Cancer 1989;63(3):490-5.
1988: Gion M; Dittadi R; Munegato G; Mione R; Gurnari G; Zotti E F; Bruscagnin G
Tumor marker radioimmunoassays in gastric juice. Methodologic drawbacks due to pH variations.
Gastroenterology 1988;94(6):1271-5.
1988: Dittadi R; Mione R; Gion M; Leon A; Bruscagnin G
Biochemical parameters in the cytosol of breast cancer.
The International journal of biological markers 1988;3(1):70.
1986: Gion M; Mione R; Dittadi R; Fasan S; Pallini A; Bruscagnin G
Carcinoembryonic antigen, ferritin, and tissue polypeptide antigen in serum and tissue. Relationship with the receptor content in breast carcinoma.
Cancer 1986;57(5):917-22.
1986: Gion M; Mione R; Dittadi R; Griggio L; Munegato G; Valsecchi M; Del Maschio O; Bruscagnin G
Carcinoembryonic antigen, ferritin, tissue polypeptide antigen, and CA15/3 in breast cancer: relationship between carcinoma and normal breast tissue.
The International journal of biological markers 1986;1(1):33-8.
1986: Gion M; Mione R; Dittadi R; Fasan S; Pallini A; Bruscagnin G
Evaluation of CA15/3 serum levels in breast cancer patients.
The Journal of nuclear medicine and allied sciences 1986;30(1):29-36.
1985: Gion M; Mione R; Dittadi R; Griggio L; Munegato G; Valescchi M; Del Maschio O; Fasan S; Bruscagnin G
Estrogen and progesterone receptors in breast carcinoma and in nonmalignant breast tissue.
Tumori 1985;71(5):477-81.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Massimo Gion

Research Profile (preview)

Chemicals & Drugs

Disorders

Anatomy

Procedures

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Massimo Gion (preview)

All Publications